Predictix ™ - a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report on the efficacy of antidepressants and their side effects

Project Information

Predictix

Grant agreement ID: 874082

DOI

10.3030/874082

Project closed

EC signature date 19 October 2020

Start date 1 September 2020

End date 31 August 2023

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost

€ 3 545 737,50

EU contribution

€ 2 482 016,25

Coordinated by

TALIAZ LTD
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (2)

Project Website
CE mark approval according to the MDR 2017/745

CE mark approval according to the MDR 2017745

Publications

Peer reviewed articles (4)

Impact of a Personalized Antidepressant Prescription Using Genetics, Socio-Demographic and Clinical Data in Major Depressive Disorder Patients: A Clinical Pilot Study: This paper was are the results of the initial clinical pilot with APHP and was published in Pharmacology and Pharmacogenetics

Author(s): Bertrand Saudreau, Amit Spinrad, Redwan Maatoug, Nourredine Haddadi, Raphaël Saffroy, Antoinette Lemoinee, Roy Schurr, Sne Darki-Morag, Roni Zoller, Dekel Taliaz, Bruno Millet
Published in: Pharmacology and Pharmacogenomics, Issue 00000000, 2022, Page(s) 10, ISSN 0000-0000
Publisher: Pharmacology and Pharmacogenomics
DOI: 10.31488/jpp.105

Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data

Author(s): Dekel Taliaz, Amit Spinrad, Ran Barzilay, Zohar Barnett-Itzhaki, Dana Averbuch, Omri Teltsh, Roy Schurr, Sne Darki-Morag, Bernard Lerer
Published in: Translational Psychiatry, Issue 11/1, 2021, Page(s) 9, ISSN 2158-3188
Publisher: Nature Publishing Group
DOI: 10.1038/s41398-021-01488-3

Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path

Author(s): Dekel Taliaz and Prof. Alessandro Serretti
Published in: CNS & Neurological Disorders - Drug Targets, Issue 18715273, 2022, Page(s) 8, ISSN 1871-5273
Publisher: Bentham Science Publishers
DOI: 10.2174/1871527321666220628103843

A New Characterization of Mental Health Disorders Using Digital Behavioral Data: Evidence from Major Depressive Disorder

Author(s): Dekel Taliaz, Daniel Souery
Published in: Journal of Clinical Medicine, Issue 10/14, 2021, Page(s) 3109, ISSN 2077-0383
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/jcm10143109

Intellectual Property Rights

Trademark (1)

PREDICTIX

Application/Publication number: EU 018083065
Date: 2020-12-03
Applicant(s): TALIAZ LTD